Monitor for any future conversion to a Schedule 13D, which would signal a shift to activist intent. No immediate catalyst from this routine passive filing.
Price Chart
Executive Summary
BlackRock, Inc. filed an amended Schedule 13G disclosing a 7.2% passive stake in First Tracks Biotherapeutics, Inc. as of September 30, 2026, representing 2,558,473 shares. This is a routine update for a large passive institutional holder; no change in investment intent or control is indicated.
Key Financial Metrics
Key Facts
- BlackRock reported beneficial ownership of 2,558,473 shares of First Tracks Biotherapeutics common stock as of September 30, 2026.
- The stake represents 7.2% of the outstanding shares.
- The filing is an amendment to a Schedule 13G, indicating passive investment intent under Rule 13d-1(b).
- BlackRock disclaims any purpose or effect of changing or influencing control of the issuer.
Financial Impact
Passive stake of 7.2% valued at approximately $129.6 million based on $1.8B market cap.
Risk Factors
- No material risks identified from this routine passive stake amendment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0002012383-26-003898 |
| Document: Item_7.txt | 0002012383-26-003898 |
| Document: 0002012383-26-003898-index-headers.html | 0002012383-26-003898 |
| Document: 0002012383-26-003898-index.html | 0002012383-26-003898 |
| Document: 0002012383-26-003898.txt | 0002012383-26-003898 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 30, 2026 2d ago | EFFECT | $45.23 | awaiting T+1 | awaiting T+1 | $45.08 (+0.33%) |
Oct 27, 2026 4d ago | SC 13G/A | $45.72 $45.23 | ▼ −1.08% | ▼ −0.70% | $45.08 (−1.40%) |
Oct 26, 2026 6d ago | S-1 | $43.48 $45.38 | ▲ +4.37% | ▲ +3.81% | $45.08 (+3.68%) |
Oct 20, 2026 11d ago | 8-K | $42.77 $43.14 | ▲ +0.87% | ▲ +2.05% | $45.08 (+5.40%) |
Oct 15, 2026 16d ago | 8-K | $34.46 $36.28 | ▼ −5.28% | ▼ −4.86% | $45.08 (−30.82%) |
Oct 15, 2026 17d ago | Press Release | $36.04 $34.46 | ▲ +4.38% | ▲ +3.28% | $45.08 (−25.08%) |
Oct 13, 2026 19d ago | 8-K | $31.68 $34.13 | ▲ +7.73% | ▲ +8.81% | $45.08 (+42.30%) |
Aug 12, 2026 11w ago | 8-K | No price | awaiting T+1 | awaiting T+1 | No price |
Aug 12, 2026 11w ago | Press Release | $44.03 $44.04 | ▲ +0.02% | ▲ +0.22% | $45.08 (+2.38%) |
Aug 7, 2026 12w ago | 3/A | $47.92 $46.75 | ▼ −2.44% | ▼ −2.12% | $45.08 (−5.93%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers